NCT05929976 InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort Status RECRUITING Phase N/A
NCT05887167 Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies Status RECRUITING Phase PHASE1
NCT05866887 Insomnia Prevention in Children With Acute Lymphoblastic Leukemia Status COMPLETED Phase NA
NCT05811845 Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALL Status RECRUITING Phase N/A
NCT05809167 Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT Status RECRUITING Phase PHASE2
NCT05800210 Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases Status RECRUITING Phase PHASE2
NCT05776134 Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel Status AVAILABLE Phase N/A
NCT05774990 Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia Treatment Status COMPLETED Phase N/A
NCT05772000 Clinical Significance of Occult Central Nervous System Localization Status UNKNOWN Phase N/A
NCT05751044 HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT05748171 A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL Status RECRUITING Phase PHASE2
NCT05739227 Safety and Efficacy of Allogenic CD19-CAR-NK Cells in Treatmenting r/r B-cell Hematologic Malignancies Status UNKNOWN Phase EARLY_PHASE1
NCT05735717 MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies Status RECRUITING Phase PHASE2
NCT05694364 Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT05687032 A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE4
NCT05679817 How Effective is the Dose-graded Aerobic Training in Children Survivors of Acute Lymphoblastic Leukemia? Status COMPLETED Phase NA
NCT05639673 Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia Status RECRUITING Phase N/A